
News|Articles|May 1, 2003
Coreg (Carvedilol) GlaxoSmithKline
b-blocker indicated for reducingcardiovascular mortality
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
National Alliance survey shows employers are leaving the ‘big 3’ for other PBMs
2
7 takeaways from the MHE webinar on PBM reform and transparency
3
Novo Nordisk's ziltivekimab falls short to reduce cardiovascular events in phase 3 trial
4
What employees may miss when they buy drugs directly online
5





















